Atom | Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)

Due Dates: July 14, 2025 (Letter of Intent & Open Date) | August 14, 2025 (Application Due)

Funding Amounts: Up to $700,000 direct costs per year, max 5 years; total program funding $2,000,000; up to 3 awards expected.

Summary: Supports high-risk, high-impact exploratory studies on mechanisms of HIV infection, replication, latency, and pathogenesis in the context of substance use disorders (SUDs); clinical trials are not allowed.

Key Information: Applications must address both HIV mechanisms and SUD context; at least one aim must involve addictive substances or related pathways; non-responsive applications will be withdrawn without review.

Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing